Hundreds of Lowcountry moms danced the night away all in support of research to support a treatment for a genetic disorder.

Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood.

Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...

An inhaled gene therapy for cystic fibrosis developed by Boehringer Ingelheim is due to start clinical testing shortly, hoping to become a first-in-class treatment for the genetic disorder.

In adults with cystic fibrosis, gastrointestinal symptoms initially improve with ETI but most do not consistently improve with longer-term use.

The global Cystic Fibrosis Market is valued at $10.4 billion in 2023 and is projected to reach $55.4 billion by 2032, ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC) 1 and OXB, 1 today announce the start of LENTICLAIR TM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Here's what cystic fibrosis is, what causes it and how it's usually treated once it has been diagnosed. Cystic fibrosis (CF) is a progressive genetic disease that adversely affects a person's ...